DRS

#900
Leonardo DRS, Inc. - Common Stock
38.5 4 USD
-0.01%
Market Price
Sektor: Industrie
Basis: USD
Gewinnwährung: USD
Tagesspanne
38.54
38.54
Jahresspanne
32.43
50.59
Tagesänderung
-0.98%
Monatliche Änderung
-15.87%
6 month change
-14.41%
Jahresänderung
-6.16%
Vorheriger Schlusskurs
38.9 2
Open
38.5 4
Tief
38.5 4
Hoch
38.5 4
Volumen
103
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden Documents

2026

Current report, Q3 FY2026
Leonardo DRS, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Leonardo DRS, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Leonardo DRS, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Leonardo DRS, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Leonardo DRS, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Leonardo DRS, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Leonardo DRS, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Leonardo DRS, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Leonardo DRS, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Leonardo DRS, Inc. current report, Q1 FY2026
8-K

Leonardo DRS, Inc. current report, Q1 FY2026

Full document

Leonardo DRS, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Leonardo DRS, Inc. on March 10, 2026, covering events occurring on March 5 and March 6, 2026. The filing addresses changes to the composition of the Board of Directors, specifically the retirement of a proxy holder director and the appointment of a successor, as well as the reappointment of another proxy holder director.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and does not contain financial performance data.

Material Changes

  • Director Retirement: David W. Carey informed the Board on March 6, 2026, of his decision to retire effective March 31, 2026. Mr. Carey served on the Board since 2009 and chaired the Government Security Committee. His departure is not due to any disagreement with the Company.
  • Director Appointment: Reuben Jeffery III was appointed as a Class C proxy holder director, effective April 1, 2026, to fill the vacancy left by Mr. Carey. His term expires March 31, 2029. He will serve on the Audit, Nominating and Corporate Governance, and Government Security Committees.
  • Director Reappointment: Dr. Louis Brothers was reappointed as a Class C proxy holder director for a term extending through March 31, 2029, effective April 1, 2026.

Guidance, Outlook, and Risks

The filing contains no financial guidance, outlook, or management commentary regarding future business performance. No new risks, contingencies, or unusual items were disclosed in this report. The appointment of Mr. Jeffery was approved by the Defense Counterintelligence Security Agency pursuant to the Proxy Agreement.

Key Facts for Investor Verification

  • Verify the effective dates of the Board changes (April 1, 2026) and the expiration of the new terms (March 31, 2029).
  • Confirm the specific committee assignments for the new director, Reuben Jeffery III.
  • Review the definitive proxy statement on Schedule 14A filed on April 23, 2025, for details on standard non-employee director compensation.
  • Note that the filing explicitly states no disagreement exists regarding Mr. Carey's retirement.

Nachrichten